BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 25539849)

  • 1. The oncogenic and prognostic potential of eight microRNAs identified by a synergetic regulatory network approach in lung cancer.
    Mitra R; Zhao Z
    Int J Comput Biol Drug Des; 2014; 7(4):384-93. PubMed ID: 25539849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reproducible combinatorial regulatory networks elucidate novel oncogenic microRNAs in non-small cell lung cancer.
    Mitra R; Edmonds MD; Sun J; Zhao M; Yu H; Eischen CM; Zhao Z
    RNA; 2014 Sep; 20(9):1356-68. PubMed ID: 25024357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel framework for inferring condition-specific TF and miRNA co-regulation of protein-protein interactions.
    Zhang J; Le TD; Liu L; He J; Li J
    Gene; 2016 Feb; 577(1):55-64. PubMed ID: 26611531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical implication of microrna for lung cancer.
    Wang Y; Zhang X; Liu L; Li H; Yu J; Wang C; Ren X
    Cancer Biother Radiopharm; 2013 May; 28(4):261-7. PubMed ID: 23496233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systems biology approach for miRNA-mRNA expression patterns analysis in non-small cell lung cancer.
    Najafi A; Tavallaei M; Hosseini SM
    Cancer Biomark; 2016; 16(1):31-45. PubMed ID: 26484609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis.
    Chen X; Hu Z; Wang W; Ba Y; Ma L; Zhang C; Wang C; Ren Z; Zhao Y; Wu S; Zhuang R; Zhang Y; Hu H; Liu C; Xu L; Wang J; Shen H; Zhang J; Zen K; Zhang CY
    Int J Cancer; 2012 Apr; 130(7):1620-8. PubMed ID: 21557218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional analysis of microRNA and transcription factor synergistic regulatory network based on identifying regulatory motifs in non-small cell lung cancer.
    Li K; Li Z; Zhao N; Xu Y; Liu Y; Zhou Y; Shang D; Qiu F; Zhang R; Chang Z; Xu Y
    BMC Syst Biol; 2013 Nov; 7():122. PubMed ID: 24200043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer.
    Foss KM; Sima C; Ugolini D; Neri M; Allen KE; Weiss GJ
    J Thorac Oncol; 2011 Mar; 6(3):482-8. PubMed ID: 21258252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. microRNA and Lung Cancer.
    Del Vescovo V; Denti MA
    Adv Exp Med Biol; 2015; 889():153-77. PubMed ID: 26659001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased expression of miR-204 in plasma is associated with a poor prognosis in patients with non-small cell lung cancer.
    Guo W; Zhang Y; Zhang Y; Shi Y; Xi J; Fan H; Xu S
    Int J Mol Med; 2015 Dec; 36(6):1720-6. PubMed ID: 26497897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNAs: A novel potential biomarker for diagnosis and therapy in patients with non-small cell lung cancer.
    Zhou Q; Huang SX; Zhang F; Li SJ; Liu C; Xi YY; Wang L; Wang X; He QQ; Sun CC; Li DJ
    Cell Prolif; 2017 Dec; 50(6):. PubMed ID: 28990243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the Key miRNAs and Genes Associated with the Regulation of Non-Small Cell Lung Cancer: A Network-Based Approach.
    Shafat Z; Ahmed MM; Almajhdi FN; Hussain T; Parveen S; Ahmed A
    Genes (Basel); 2022 Jun; 13(7):. PubMed ID: 35885958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic, therapeutic and diagnostic potential of microRNAs in non-small cell lung cancer.
    Markou A; Liang Y; Lianidou E
    Clin Chem Lab Med; 2011 Oct; 49(10):1591-603. PubMed ID: 21767219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-150, p53 protein and relevant miRNAs consist of a regulatory network in NSCLC tumorigenesis.
    Wang DT; Ma ZL; Li YL; Wang YQ; Zhao BT; Wei JL; Qi X; Zhao XT; Jin YX
    Oncol Rep; 2013 Jul; 30(1):492-8. PubMed ID: 23670238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting Diagnostic Gene Biomarkers for Non-Small-Cell Lung Cancer.
    Liang B; Shao Y; Long F; Jiang SJ
    Biomed Res Int; 2016; 2016():3952494. PubMed ID: 27579312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-free microRNAs as diagnostic, prognostic, and predictive biomarkers for lung cancer.
    Zandberga E; Kozirovskis V; Ābols A; Andrējeva D; Purkalne G; Linē A
    Genes Chromosomes Cancer; 2013 Apr; 52(4):356-69. PubMed ID: 23404859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reconstruction and analysis of transcription factor-miRNA co-regulatory feed-forward loops in human cancers using filter-wrapper feature selection.
    Peng C; Wang M; Shen Y; Feng H; Li A
    PLoS One; 2013; 8(10):e78197. PubMed ID: 24205155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of miR-374a as a prognostic marker for survival in patients with early-stage nonsmall cell lung cancer.
    Võsa U; Vooder T; Kolde R; Fischer K; Välk K; Tõnisson N; Roosipuu R; Vilo J; Metspalu A; Annilo T
    Genes Chromosomes Cancer; 2011 Oct; 50(10):812-22. PubMed ID: 21748820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Participation of microRNAs in human interactome: extraction of microRNA-microRNA regulations.
    Sengupta D; Bandyopadhyay S
    Mol Biosyst; 2011 Jun; 7(6):1966-73. PubMed ID: 21483898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-coding RNA profile in lung cancer.
    Ghafouri-Fard S; Shoorei H; Branicki W; Taheri M
    Exp Mol Pathol; 2020 Jun; 114():104411. PubMed ID: 32112788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.